| | A federal appeal court on Friday questioned whether it had the power to override an act of Congress that gave Rio Tinto Ltd land in Arizona for its Resolution copper mine, which has been challenged by Native Americans. | | | The S&P 500 and Nasdaq closed lower on Friday as disappointing quarterly reports from Snap Inc and Intel Corp put pressure on the communications and technology sectors and investors turned skittish as Federal Reserve Chair Jerome Powell discussed stimulus tapering. | | | German solar car firm Sono Motors on Friday filed for a U.S. initial public offering (IPO), looking to cash in on investor demand as governments worldwide push for a shift to greener transport. | | | Ratings agency S&P Global on Friday raised Italy's outlook to "positive" from "stable", saying the government's commitment to pro-growth reforms would boost the economy. | | | Mexico's agriculture minister said the country would not limit imports of genetically modified (GMO) corn from the United States during a meeting with U.S. Agriculture Secretary Tom Vilsack in Iowa on Wednesday. | | | The ousted chairman of Canada's Rogers Communications Inc laid out plans to regain control of the board in the latest twist to a feud over who should lead one of Canada's biggest telecoms companies. | | | Exxon Mobil Corp plans to close two Houston-area office towers to consolidate staff in its main campus as it cuts costs following staff departures, the company said on Friday. | | | The S&P 500 and Nasdaq closed lower on Friday as disappointing quarterly reports from Snap Inc and Intel Corp dragged down the communications and technology sectors and investors turned skittish as Federal Reserve Chair Jerome Powell discussed stimulus tapering. | | | The S&P 500 and Nasdaq were in the red on Friday after Federal Reserve Chair Jerome Powell discussed stimulus tapering while disappointing quarterly reports from Snap Inc and Intel Corp pushed the communications and technology sectors lower. | | | Swiss drugmaker Roche Holding AG said on Friday the U.S. health regulator approved its eye implant for patients with a chronic disorder causing blurred vision, giving them an alternative to receiving monthly eye injections with existing treatments. | | | | |